Lung Cancer And Me:
Different Types. Different Journeys.

Lung cancer is one of the most common forms of cancer with more than 2,000,000 people diagnosed worldwide each year and is the leading cause of cancer death globally.1-3 From diagnosis to treatment, each lung cancer patient has their own unique journey.

Lung Cancer Awareness Month 2018

To increase awareness and understanding of this complex disease, and how it can affect the lives of patients and those around them, we’re sharing the different journeys of lung cancer patients, carers, and patient groups, as well as our own. 


A family perspective

Like any serious illness, lung cancer has a far reaching impact, not only on the patient diagnosed and going through treatment, but also on their caregivers and families.


The complexity of lung cancer

Understanding lung cancers and what drives them is hugely important for doctors in determining the best treatment for patients.


Why lung cancer research matters

Dramatic advancements in the understanding of lung cancer over the years has lead to better outcomes for patients.

Greater understanding of subtypes and how different gene fusions or rearrangements drive cancer cell growth and survival, has allowed for the development of new tests and treatments for lung cancer and has transformed the patient journey.

I am very happy to be an advocate these days because so many good things have started to happen in the last three, four, five years. The number of survivors are increasing all the time, so it is very good to be able to say that."
Tommy Björk, Board member, Lung Cancer Europe

Whether testing for PD-L1 to enable treatment with immunotherapies, or testing for gene fusions, such as ALK, EGFR or ROS1, to allow treatment with a specific targeted therapy, continued research and a holistic approach to lung cancer diagnosis and treatment is core to providing effective options for every person diagnosed with the disease.

Roche perspective

We recognise that each patient's lung cancer journey is different.



  1. World Health Organization. Cancer. [Internet; cited October 2018]. Available from:
  2. World Health Organization. GLOBOCAN 2018; Lung Cancer: Estimated cancer incidence, mortality and prevalence worldwide. [Internet]: Accessed October 2018.
  3. Cancer Research UK. Worldwide Cancer Statistics. [Internet; cited October 2018]
  4. American Cancer Society. What Is Non-Small Cell Lung Cancer? [Internet; cited October 2018]. Available from:
  5. MedicineNet. Non-Small Cell Lung Cancer vs. Small Cell Lung Cancer. [Internet; cited October 2018]. Available from:
  6. Jain P et al. Role of immune-checkpoint inhibitors in lung cancer. Ther Adv Respir Dis. 2018:12;1753465817750075.

Tags: Patients